Michael L. Miller

3.8k total citations · 1 hit paper
68 papers, 2.7k citations indexed

About

Michael L. Miller is a scholar working on Oncology, Organic Chemistry and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael L. Miller has authored 68 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 20 papers in Organic Chemistry and 19 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael L. Miller's work include HER2/EGFR in Cancer Research (18 papers), Monoclonal and Polyclonal Antibodies Research (17 papers) and Cancer Treatment and Pharmacology (9 papers). Michael L. Miller is often cited by papers focused on HER2/EGFR in Cancer Research (18 papers), Monoclonal and Polyclonal Antibodies Research (17 papers) and Cancer Treatment and Pharmacology (9 papers). Michael L. Miller collaborates with scholars based in United States, Canada and United Kingdom. Michael L. Miller's co-authors include Ravi Chari, Wayne C. Widdison, Yi Shi, Anthony J. Di Pasqua, Iwao Ojima, J. P. Heppner, Xudong Geng, Songnian Lin, Cristian Vaccari and Rajeeva Singh and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Michael L. Miller

64 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibody–Drug Conjugates: An Emerging Concept in Cancer Therapy

2014 759 citations Ravi Chari, Michael L. Miller et al. Angewandte Chemie International Edition profile →

Peers

Michael L. Miller

ONCOL

RNMI

BIOMA

I. David Goldman United States

Carlo M. Cipolla Italy

Robert J. Jones United Kingdom

Robert C. Johnson United States

James Ferguson United Kingdom

José Antonio Ortega United States

Susan Scott United Kingdom

Alison Jones United Kingdom

Robert Jackson United States

Richard Callaghan United Kingdom

I. David Goldman United States

Michael L. Miller

2.2k ×2.4

ONCOL

4.1k ×4.6

246 ×0.3

RNMI

365 ×0.7

332 ×1.2

BIOMA

Citations per year, relative to Michael L. Miller Michael L. Miller (= 1×) peers I. David Goldman

Countries citing papers authored by Michael L. Miller

Since Specialization

Citations

This map shows the geographic impact of Michael L. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Miller more than expected).

Fields of papers citing papers by Michael L. Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael L. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Miller. The network helps show where Michael L. Miller may publish in the future.

Co-authorship network of co-authors of Michael L. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Michael L. Miller. A scholar is included among the top collaborators of Michael L. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael L. Miller. Michael L. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Jae Eun, et al.. (2024). Defective glycosylation and ELFN1 binding of mGluR6 congenital stationary night blindness mutants. Life Science Alliance. 8(3). e202403118–e202403118. 1 indexed citations

Miller, Michael L., et al.. (2024). Complex N-glycosylation of mGluR6 is required for trans-synaptic interaction with ELFN adhesion proteins. Journal of Biological Chemistry. 300(4). 107119–107119. 2 indexed citations

Ponte, Jose F., Leanne Lanieri, Eshita Khera, et al.. (2020). Antibody Co-Administration Can Improve Systemic and Local Distribution of Antibody–Drug Conjugates to Increase In Vivo Efficacy. Molecular Cancer Therapeutics. 20(1). 203–212. 29 indexed citations

Miller, Michael L. & Cristian Vaccari. (2020). Digital Threats to Democracy: Comparative Lessons and Possible Remedies. The International Journal of Press/Politics. 25(3). 333–356. 46 indexed citations

Miller, Michael L., Nathan Fishkin, Wěi Li, et al.. (2016). A New Class of Antibody–Drug Conjugates with Potent DNA Alkylating Activity. Molecular Cancer Therapeutics. 15(8). 1870–1878. 65 indexed citations

Chari, Ravi, Michael L. Miller, & Wayne C. Widdison. (2014). Antibody–Drug Conjugates: An Emerging Concept in Cancer Therapy. Angewandte Chemie International Edition. 53(15). 3796–3827. 759 indexed citations breakdown →

Shi, Yi, et al.. (2014). Platinum(IV) cisplatin derivative trans, cis, cis-bis(heptanoato)amine(cyclohexylamine)dichloridoplatinum(IV) has an enhanced therapeutic index compared to cisplatin for the treatment of non-small cell lung cancer. Inorganica Chimica Acta. 423. 215–219. 6 indexed citations

Leon, J., Daniel A. Jaffe, J. Kašpar, et al.. (2011). Arrival time and magnitude of airborne fission products from the Fukushima, Japan, reactor incident as measured in Seattle, WA, USA. Journal of Environmental Radioactivity. 102(11). 1032–1038. 111 indexed citations

Hannig, Christian, Bettina Spitzmüller, Michael L. Miller, Elmar Hellwig, & Matthias Hannig. (2008). Intrinsic enzymatic crosslinking and maturation of the in situ pellicle. Archives of Oral Biology. 53(5). 416–422. 34 indexed citations

10.

Reddy, Joseph A., Elaine Westrick, Hari Krishna R. Santhapuram, et al.. (2007). Folate Receptor–Specific Antitumor Activity of EC131, a Folate-Maytansinoid Conjugate. Cancer Research. 67(13). 6376–6382. 67 indexed citations

11.

Ojima, Iwao, Christopher P. Borella, Pierre‐Yves Bounaud, et al.. (2005). Design, Synthesis and Structure−Activity Relationships of Novel Taxane-Based Multidrug Resistance Reversal Agents. Journal of Medicinal Chemistry. 48(6). 2218–2228. 28 indexed citations

12.

Miller, Michael L., et al.. (2004). Synthesis of potent taxoids for tumor-specific delivery using monoclonal antibodies. Bioorganic & Medicinal Chemistry Letters. 14(15). 4079–4082. 11 indexed citations

13.

Baloglu, Erkan, et al.. (2004). Synthesis and biological evaluation of novel taxoids designed for targeted delivery to tumors. Bioorganic & Medicinal Chemistry Letters. 14(23). 5885–5888. 15 indexed citations

14.

Miller, Michael L., Robert Y. Zhao, Barbara A. Leece, et al.. (2004). Synthesis of Taxoids with Improved Cytotoxicity and Solubility for Use in Tumor-Specific Delivery. Journal of Medicinal Chemistry. 47(20). 4802–4805. 19 indexed citations

15.

Geng, Xudong, Michael L. Miller, Songnian Lin, & Iwao Ojima. (2003). Synthesis of Novel C2−C3‘N-Linked Macrocyclic Taxoids by Means of Highly Regioselective Heck Macrocyclization. Organic Letters. 5(20). 3733–3736. 40 indexed citations

16.

Ojima, Iwao, Tao Wang, Michael L. Miller, et al.. (1999). Synthesis and structure-activity relationships of new second-generation taxoids. Bioorganic & Medicinal Chemistry Letters. 9(24). 3423–3428. 60 indexed citations

17.

Miller, Michael L. & Partha S. Ray. (1997). A Convenient Synthesis of 2,2,4-Trimethylcyclohexane-1,3-Dione: A Useful Precursor for The Taxoid a Ring. Synthetic Communications. 27(22). 3991–3996. 2 indexed citations

18.

Fuselier, S. A., S. B. Mende, S. P. Geller, et al.. (1994). Dynamics of the CRRES barium releases in the magnetosphere. Journal of Geophysical Research Atmospheres. 99(A9). 17379–17389. 5 indexed citations

19.

Segal, Glenn H., Raymond R. Tubbs, Norman B. Ratliff, Michael L. Miller, & David L. Longworth. (1990). Thrombotic thrombocytopenic purpura in a patient with AIDS. Cleveland Clinic Journal of Medicine. 57(4). 360–366. 14 indexed citations

20.

Heppner, J. P., B. G. Ledley, Michael L. Miller, et al.. (1989). Search for auroral belt E_∥ fields with high‐velocity barium ion injections. Journal of Geophysical Research Atmospheres. 94(A1). 393–425. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact